The role of senescent beta cells in T1D and T2D
衰老 β 细胞在 T1D 和 T2D 中的作用
基本信息
- 批准号:10708994
- 负责人:
- 金额:$ 72.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-19 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
U01 Application: The role of senescent beta cells in T1D and T2D
Abstract
Recent studies including our own suggest a marked increase in β-cells expressing key components of cellular
senescence in islets from Type 1 diabetes (T1D) and Type 2 diabetic (T2D) patients, implicating β-cell
senescence as a critical contributor to islet dysfunction. Recently, it was reported that ablation of senescent
cells by non-specific senolysis in mouse models of T1D and T2D improved diseease outcome. However, these
studies did not determine which senescent cell type was relevant to the beneficial effect, nor did they address
to what extent senescence occurs in the human endocrine pancreas before and during the development of
T1D and T2D. To close this knowledge gap, in Specific Aim 1 we will determine the prevalence, transcription
signatures and epigenomic landscapes of β-cell senescence in T1D, pre-T1D and T2D donors using
immunostaining, imaging mass cytometry, single cell RNAseq, single cell ATACseq, DNA methylome
determination and Cut-and-Tag analysis for key histone marks. In addition, we will evaluate the hypothesis that
irreparable damage to telomeres drives senescence in β-cells, a possible scenario that could provide a
mechanism for senescence to occur in islet cells of diabetic patients. In Specific Aim 2, we will test whether
metabolic and/or inflammatory stressors drive senescence in human β-cells and determine the effect of
senescence on β-cell function using scRNAseq and secretome analysis. We will evaluate if induction of
senescence and the senescence-associated secretory phenotype (SASP) in human islet cells is p16
dependent, employing the pseudo-islets approach and using our hyperglycemic xeno-transplantation model to
assess the direct effect of senolytics on human islet function. In Specific Aim 3, we will employ a novel
transgenic mouse, the ‘SenKiller’ model, to enable cell-type specific and inducible ablation of senescent cells in
any lineage including β-cells. Using this mouse model in combination with the appropriate β-cell specific Cre
driver, we will provide a definitive answer to the question if senescent β-cells are critical in the development of
glucose intolerance in models of T2D and islet autoimmunity in models of T1D. Together, this proposal will
determine the occurrence of senescence among islet cells from T1D and T2D donors using large cohorts and
multiple experimental modalities, explore the natural drivers of senescence and consequences to islet function
as well as secretion of pro-inflammatory substances, and employ novel mouse models to unequivocally
determine if elimination of senescent b-cells impacts diabetes progression in mouse models of T1D and T2D.
The data generated here will address burning questions in the field, namely, is senescence increased in islets
from diabetic patients, and are these cells important in the overall pathophysiology of T1D and T2D. These
critical questions will have therapeutic relevance regarding the potential efficacy of targeting senescent β-cells
with senolytic therapies.
U01应用:Senscent Beta细胞在T1D和T2D中的作用
抽象的
最近的研究包括我们自己的研究表明,表达细胞关键成分的β细胞显着增加
1型糖尿病(T1D)和2型糖尿病(T2D)患者的胰岛感应
感应是胰岛功能障碍的关键因素。最近,据报道,感应的消融
在T1D和T2D的小鼠模型中,通过非特异性鼻溶细胞改善了疾病结果。但是,这些
研究并未确定哪种感觉细胞类型与有益效应相关,也没有解决
在开发之前和期间,人类内分泌胰腺发生了多大程度的感受
T1D和T2D。要缩小这一知识差距,在特定目标1中,我们将确定转录的患病率
使用T1D,T1D和T2D供体中β细胞感应的特征和表观基因组景观
免疫染色,成像质量细胞术,单细胞RNASEQ,单细胞Atacseq,DNA甲基团
关键组蛋白标记的确定和剪切分析。此外,我们将评估以下假设
无法弥补的对端粒的损害驱动β细胞衰老,这种情况可能会提供
在糖尿病患者的胰岛细胞中发生感应的机制。在特定目标2中,我们将测试是否
代谢和/或炎性应激源在人β细胞中驱动感应,并确定
使用SCRNASEQ和分泌组分析对β细胞功能的感应。我们将评估是否归纳
人类胰岛细胞中的感应和与感应相关的秘书表型(SASP)是p16
依赖,采用伪islet方法,并使用我们的高血糖异种移植模型
评估鼻溶剂对人类胰岛功能的直接影响。在特定目标3中,我们将采用小说
转基因小鼠是“ senkiller”模型,以实现细胞类型的特异性并诱导的感觉细胞中的消融
包括β细胞在内的任何血统。将此小鼠模型与适当的β细胞特异性CRE结合使用
驱动程序,我们将为一个问题提供一个确定的答案,即
T1D模型中T2D和Islet自身免疫模型中的葡萄糖intlerance。在一起,这个建议将
确定使用大型队列和
多种实验方式,探索感应的自然驱动因素和胰岛功能的后果
以及促炎物质的分泌,以及员工新颖的小鼠模型,以明确地进行
确定消除感觉B细胞是否影响T1D和T2D小鼠模型中的糖尿病进展。
此处生成的数据将解决现场的燃烧问题,即胰岛中的敏感性增加
来自糖尿病患者,这些细胞在T1D和T2D的总体病理生理中很重要。这些
关键问题将具有有关靶向senscentβ细胞的潜在有效性的热相关性
塞溶剂疗法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
KLAUS H KAESTNER的其他基金
The role of senescent beta cells in T1D and T2D
衰老 β 细胞在 T1D 和 T2D 中的作用
- 批准号:1058368410583684
- 财政年份:2022
- 资助金额:$ 72.13万$ 72.13万
- 项目类别:
Innovative Genetic Approaches to Enhance Liver Repopulation and Reduce Cancer Risk and Progression
增强肝脏再生并降低癌症风险和进展的创新遗传学方法
- 批准号:1043481310434813
- 财政年份:2020
- 资助金额:$ 72.13万$ 72.13万
- 项目类别:
Innovative Genetic Approaches to Enhance Liver Repopulation and Reduce Cancer Risk and Progression
增强肝脏再生并降低癌症风险和进展的创新遗传学方法
- 批准号:1021706210217062
- 财政年份:2020
- 资助金额:$ 72.13万$ 72.13万
- 项目类别:
Innovative Genetic Approaches to Enhance Liver Repopulation and Reduce Cancer Risk and Progression
增强肝脏再生并降低癌症风险和进展的创新遗传学方法
- 批准号:1065462710654627
- 财政年份:2020
- 资助金额:$ 72.13万$ 72.13万
- 项目类别:
The Human Pancreas Analysis Program for Type 2 Diabetes
2 型糖尿病人类胰腺分析项目
- 批准号:1025295710252957
- 财政年份:2019
- 资助金额:$ 72.13万$ 72.13万
- 项目类别:
The Human Pancreas Analysis Program for Type 2 Diabetes
2 型糖尿病人类胰腺分析项目
- 批准号:1002097310020973
- 财政年份:2019
- 资助金额:$ 72.13万$ 72.13万
- 项目类别:
The Human Pancreas Analysis Program for Type 2 Diabetes
2 型糖尿病人类胰腺分析项目
- 批准号:1067523610675236
- 财政年份:2019
- 资助金额:$ 72.13万$ 72.13万
- 项目类别:
The Human Pancreas Analysis Program for Type 2 Diabetes
2 型糖尿病人类胰腺分析项目
- 批准号:1056898510568985
- 财政年份:2019
- 资助金额:$ 72.13万$ 72.13万
- 项目类别:
The Human Pancreas Analysis Program for Type 2 Diabetes
2 型糖尿病人类胰腺分析项目
- 批准号:1026166910261669
- 财政年份:2019
- 资助金额:$ 72.13万$ 72.13万
- 项目类别:
Regulatory cascades in gastrointestinal proliferation
胃肠道增殖的调节级联反应
- 批准号:94748689474868
- 财政年份:2017
- 资助金额:$ 72.13万$ 72.13万
- 项目类别:
相似国自然基金
玛纳斯河流域上游吸收性气溶胶来源及其对积雪消融的影响研究
- 批准号:42307523
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
面向肝癌射频消融的智能建模与快速动力学分析方法研究及其临床验证
- 批准号:62372469
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
IRF9调控CD8+T细胞介导微波消融联合TIGIT单抗协同增效抗肿瘤的作用机制
- 批准号:82373219
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
建立可诱导细胞消融系统揭示成纤维细胞在墨西哥钝口螈肢体发育及再生中的作用
- 批准号:32300701
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
肿瘤源PPIA介导结直肠癌肝转移射频消融术残瘤化疗抵抗的机制研究
- 批准号:82302332
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Deciphering molecular mechanisms controlling age-associated uterine adaptabilityto pregnancy
破译控制与年龄相关的子宫妊娠适应性的分子机制
- 批准号:1063657610636576
- 财政年份:2023
- 资助金额:$ 72.13万$ 72.13万
- 项目类别:
Species-Specific Epigenetic Basis of Zebrafish Inner Ear Hair Cell Regeneration
斑马鱼内耳毛细胞再生的物种特异性表观遗传基础
- 批准号:1073276110732761
- 财政年份:2022
- 资助金额:$ 72.13万$ 72.13万
- 项目类别:
The role of senescent beta cells in T1D and T2D
衰老 β 细胞在 T1D 和 T2D 中的作用
- 批准号:1058368410583684
- 财政年份:2022
- 资助金额:$ 72.13万$ 72.13万
- 项目类别:
Targeting vascular dysfunction to promote lung repair and fibrosis resolution
针对血管功能障碍促进肺修复和纤维化消退
- 批准号:1044434210444342
- 财政年份:2022
- 资助金额:$ 72.13万$ 72.13万
- 项目类别:
Targeting vascular dysfunction to promote lung repair and fibrosis resolution
针对血管功能障碍促进肺修复和纤维化消退
- 批准号:1058458910584589
- 财政年份:2022
- 资助金额:$ 72.13万$ 72.13万
- 项目类别: